https://www.lezdotechmed.com/blog/mass-tort/fluoroquinolone-antibiotic/
Fluoroquinolone antibiotics have been approved by the FDA (Food and Drug Administration) to prevent a number of bacterial diseases, including gonococcal diseases, gastroenteritis infections, urinary tract infections, infections inside the abdomen and septicemia, infections in the bones and joints, and skin and soft tissue infections. The FDA further advised against using this medication for anything but serious issues.More than 60 generic variations are available. Fluoroquinolone antibiotics include Levaquin, Avelox, Maxaquin, Noroxin, Raxar, Cipro, Zagam, and Factive, among others.
The US Food and Drug Administration has directed fluoroquinolone producers to inform physicians and patients about the elevated risk associated with their medications. The most severe “black box” warning should be included on drug labels and prescribing instructions, and manufacturers must also produce a patient care guide.
More than 1,260 suits have been filed as part of the mass litigation. Court records state that a number have been resolved for secretive amounts. As of July 2019, only 471 lawsuits were still outstanding in the MDL. Fluoroquinolones were recently restricted by the FDA to treating only the most severe bacterial infections because of their severe side effects, which exceeded any potential advantages. As a result, the producers of fluoroquinolone antibiotics were the target of numerous lawsuits.
In November 2010, Ortho-McNeil Pharmaceutical Inc. was the subject of the first bellwether trial, which often ends with a jury finding in favour of the appellant. The jury's $700,000 verdict for compensatory damages for the plaintiff was ultimately lowered to $630,000. A civil penalty award of $1,150,000 was also made by the jury.
The second and third bellwether trials were held in January and June of each subsequent year. Both Johnson & Johnson and Ortho-McNeil Pharmaceutical Inc. received favourable jury decisions. In all, the MDL got about 2,049 actions. Records show that hundreds of cases have been resolved.
The most popular fluoroquinolone brands, with many lawsuits filed against them, are Cipro (ciprofloxacin) by Bayer HealthCare Pharmaceuticals, Inc., Avelox (moxifloxacin) by Merck & Co., Inc., and Levaquin (levofloxacin) by Johnson & Johnson. Additionally, they were the most widely used antibiotics in the US.
Individual lawsuits are filed for these issues, not class actions. Due to the large number of personal injury trial at court., judges have consolidated them into large groups known as “multidistrict litigations,” or MDLs, in order to reduce litigation time and costs.
You may be able to file a lawsuit against the manufacturer under both mass tort and product liability claims against the manufacturer of the fluoroquinolone used in your surgery. Arranging the medical charts in chronological order would help the attorney study the medical events more effectively. Therefore, your medical records are an important element in the success of your lawsuit on fluoroquinolone antibiotic.
fluoroquinoloneantibioticslawsuits
fluoroquinolonesblackboxwarning2021
fluoroquinoloneantibioticsclassactionlawsuit
